✦ LIBER ✦

The stability constant of 99mTc-DTPA complex

✍ Scribed by V.I. Levin; M.A. Gracheva; O.N. Ilyushchenko

Publisher: Elsevier Science
Year: 1980
Weight: 271 KB
Volume: 31
Category: Article
ISSN: 0020-708X
DOI: 10.1016/0020-708x(80)90131-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The labeling of DTPA-coupled proteins wi

The labeling of DTPA-coupled proteins with 99mTc

✍ D. Lanteigne; D.J. Hnatowich 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 511 KB

Radiolabelling of thymine with 99mTc. Pr

Radiolabelling of thymine with 99mTc. Preliminary results regarding the stability and biospecificity of [99mTc]thymine

✍ Diana Chiper; Corina A. Simion; Virginia Borza; Nicolae Negoita 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 81 KB

Figure 1 [ 99m Tc]Thymine uptake by the tumor of the standard female rat (0.8 mCi [ 99m Tc]thymine in 0.2 ml injected dose). 628 D. CHIPER ET AL.

Radical scavengers and the stability of

Radical scavengers and the stability of 99mTc-radiopharmaceuticals

✍ Ralf Berger 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 396 KB

On the 99mTc-labeling of isoniazid with

On the 99mTc-labeling of isoniazid with different 99mTc cores

✍ Grace Samuel; Kanchan Kothari; Sharmila Banerjee; Tapas Das; Suresh Subramanian; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 174 KB

Recent advances in the chemistry of radiolabeling with 99m Tc such as use of the 99m Tc tricarbonyl and 99m Tc-HYNIC cores have revived interest in 99m Tc-labeling of small biomolecules and further investigation as potential radiopharmaceuticals. Isoniazid, a drug commonly used for treatment of tube

Stability of 99mTc-labeled N-substituted

Stability of 99mTc-labeled N-substituted iminodiacetic acids: Ligand exchange reaction between 99mTc-HIDA and EDTA

✍ Michael D. Loberg; Anna T. Fields 📂 Article 📅 1977 🏛 Elsevier Science ⚖ 487 KB

Bioavailability of 99mTc-Ha-paclitaxel c

Bioavailability of 99mTc-Ha-paclitaxel complex [99mTc-ONCOFID-P] in mice using four different administration routes

✍ Laura Meléndez-Alafort; Mattia Riondato; Anna Nadali; Alessandra Banzato; Davide 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB

## Abstract Paclitaxel, an anti‐tumour drug, shows good results against breast and ovarian cancer. However, its therapeutic response is associated with toxic side‐effects caused by the agent used to dissolve it. Recently paclitaxel was linked to the linear polysaccharide hyaluronic acid (HA), showi